Clinical Guidelines for Periprosthetic Fracture Care

Abstract

Periprosthetic fractures represent a complex clinical challenge in modern orthopedic practice, particularly given the increasing prevalence of joint arthroplasty procedures. This review synthesizes current clinical guidelines, epidemiological data, pathophysiological mechanisms, risk factors, clinical features, and state-of-the-art diagnostic and therapeutic strategies for periprosthetic fracture care. Emphasis is placed on recent advances, guideline-based recommendations, and practical management insights tailored for healthcare professionals. The article aims to support evidence-based decision-making, optimize patient outcomes, and highlight future directions in the field.

Introduction

Periprosthetic fractures, defined as fractures occurring in the vicinity of an orthopedic implant, most commonly around hip and knee arthroplasties, have emerged as a significant clinical issue. The increasing number of primary and revision joint replacements, coupled with an aging population, has led to a notable rise in the incidence of these injuries. Successful management demands a multidisciplinary approach, integrating orthopedic expertise, advanced imaging, and adherence to up-to-date clinical guidelines. This comprehensive review provides a structured overview of the epidemiology, pathophysiology, risk assessment, clinical presentation, diagnosis, and contemporary management of periprosthetic fractures, supported by current literature and guideline recommendations.

Epidemiology / Disease Burden

The global burden of periprosthetic fractures is rising. Epidemiological studies indicate an incidence of 0.1–18% following total hip arthroplasty (THA) and 0.3–5.5% after total knee arthroplasty (TKA), with higher rates observed in revision cases and elderly populations. The morbidity and mortality associated with these injuries are significant, often exceeding those for primary fractures due to patient comorbidities and the complexity of surgical intervention. In addition, periprosthetic fractures contribute to increased healthcare utilization, prolonged hospital stays, and substantial socioeconomic costs.

Pathophysiology

The pathogenesis of periprosthetic fractures involves a combination of mechanical and biological factors. The presence of an implant alters local bone biomechanics, creating stress risers at bone-implant interfaces. Osteolysis, stress shielding, and bone remodeling around the prosthesis can compromise bone integrity, predisposing to fracture. Additionally, cemented versus cementless fixation, implant design, and surgical technique all influence local bone quality. These factors, compounded by systemic bone loss in elderly or osteoporotic patients, increase fracture susceptibility around prosthetic components.

Risk Factors

Several patient- and implant-related risk factors predispose to periprosthetic fractures. Patient factors include advanced age, osteoporosis, female gender, rheumatoid arthritis, chronic steroid use, and previous revision surgery. Implant factors such as malalignment, loosening, poor fixation, and certain prosthesis designs (e.g., long-stemmed or modular implants) are significant contributors. Surgical technique, including intraoperative bone handling and component positioning, also plays a critical role in risk mitigation.

Clinical Features

Periprosthetic fractures typically present with acute pain, inability to bear weight, swelling, deformity, and functional impairment. In the postoperative period, the diagnosis may be confounded by baseline discomfort or limited mobility. Attention to new onset pain, audible cracking sensations, and mechanical instability are suggestive of fracture. On examination, localized tenderness, abnormal limb alignment, and crepitus may be evident. In cases of chronic or occult fractures, subtle declines in function or progressive loosening of the prosthetic component should raise clinical suspicion.

Diagnosis

Accurate diagnosis hinges on a combination of clinical evaluation and imaging. Plain radiographs remain the initial modality of choice, with anteroposterior and lateral views of the affected joint and implant. Advanced imaging such as computed tomography (CT) with metal artifact reduction, and occasionally magnetic resonance imaging (MRI) may be warranted to delineate fracture patterns, assess implant stability, and evaluate bone stock. Classification systems, including the Vancouver classification for hip and the Unified Classification System (UCS) for periprosthetic fractures, guide management by categorizing fractures based on location, implant stability, and bone quality. Laboratory workup to exclude infection (CBC, ESR, CRP) is also essential, particularly in late-presenting cases or those with systemic symptoms.

Treatment & Management

Management strategies are dictated by fracture classification, implant stability, patient comorbidities, and functional demands. Nonoperative management is reserved for nondisplaced, stable fractures with a well-fixed prosthesis and low-demand patients. Surgical options include open reduction and internal fixation (ORIF) using locking plates, cables, or cerclage wires, and revision arthroplasty with or without bone grafting for unstable or loose implants. The choice of fixation device is guided by bone quality, anatomical location, and the need to bypass stress risers. Early mobilization, venous thromboembolism prophylaxis, and multidisciplinary rehabilitation are integral to optimizing outcomes. Complications such as nonunion, infection, and implant failure necessitate vigilant follow-up and prompt intervention.

Recent Advances / Emerging Therapies

Recent advances in the management of periprosthetic fractures include the development of modular revision implants, porous metal augments, and minimally invasive surgical techniques. The use of locking plate constructs and cable-plate systems has improved fixation in osteoporotic bone. Biologic adjuncts, such as bone morphogenetic proteins and synthetic bone graft substitutes, are under investigation for enhancing fracture healing. Computer-assisted surgical planning and intraoperative navigation technologies are increasingly utilized to optimize implant positioning and alignment. Ongoing research into pharmacological agents for osteoporosis and periprosthetic bone loss may further reduce fracture risk in high-risk populations.

Guideline Recommendations

Current guidelines from organizations such as the American Academy of Orthopaedic Surgeons (AAOS) and the British Orthopaedic Association (BOA) emphasize individualized, multidisciplinary care. Key recommendations include: thorough preoperative risk assessment; adherence to validated fracture classification systems; prioritization of implant stability and bone stock restoration; and early mobilization. The use of evidence-based algorithms for surgical decision-making is encouraged, with a focus on minimizing complications and maximizing functional recovery. Guideline adherence has been shown to improve patient outcomes and reduce variability in care.

Conclusion

Periprosthetic fractures are a growing clinical challenge with significant morbidity and socioeconomic impact. Advances in surgical techniques, implant technology, and guideline-driven care have improved outcomes, but optimal management requires a nuanced, patient-centered approach. Ongoing research into fracture prevention, biomaterials, and adjunctive therapies will further refine care pathways. Adherence to current clinical guidelines, combined with vigilant perioperative management and rehabilitation, remains the cornerstone of successful periprosthetic fracture care.